Dagmar Rosa-Bjorkeson

Dagmar Rosa-Bjorkeson

Direttore/Membro del Consiglio presso
Deirdres House
62 anni
Health Technology
Consumer Services

Profilo

Dagmar Rosa-Bjorkeson currently works at New Jersey City University Foundation, as Director and Deirdres House, as Director.
Ms. Rosa-Bjorkeson also formerly worked at Intercept Pharmaceuticals, Inc., as Independent Director from 2021 to 2023, Xencor, Inc., as Independent Director from 2019 to 2025, Baxalta, Inc., as President-Biosimilars & EVP from 2014 to 2016, Novartis Pharmaceuticals Corp., as Vice President & Head-Multiple Sclerosis Business from 1997 to 2014, Hoechst Pharmaceuticals Ltd., as Sales Representative, Mallinckrodt Medical, Inc. (US), as Executive VP, Chief Strategy & Development Officer from 2017 to 2020, Novartis Sverige AB, as President, Mallinckrodt Plc, as Chief Strategy & Corporate Development Officer from 2018 to 2020, and Mesoblast Ltd., as Chief Operating Officer from 2020 to 2024.
Ms. Rosa-Bjorkeson received her undergraduate degree, graduate degree, and Masters Business Admin degree from The University of Texas at Austin.

Posizioni attive di Dagmar Rosa-Bjorkeson

SocietàPosizioneInizio
Deirdres House
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -

Precedenti posizioni note di Dagmar Rosa-Bjorkeson

SocietàPosizioneFine
XENCOR, INC. Direttore/Membro del Consiglio 12/06/2025
MESOBLAST LIMITED Direttore operativo 01/12/2024
INTERCEPT PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 08/11/2023
MALLINCKRODT PLC Corporate Officer/Principal 01/01/2020
Corporate Officer/Principal 01/01/2020
Vedi nel dettaglio l'esperienza di Dagmar Rosa-Bjorkeson

Formazione di Dagmar Rosa-Bjorkeson

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

76

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private12

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Hoechst Pharmaceuticals Ltd.

Health Technology

Health Technology

Consumer Services

Deirdres House

  1. Mercati
  2. Insiders
  3. Dagmar Rosa-Bjorkeson
ULTIMI ORARI | -40%: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA